This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: All India exam, Subject name: Pharmacology
Tildrakizumab was approved by FDA in 2018 for 
Select and explain. 
A. Cystic fibrosis, B. Migraine, C. Hypeension, D. Psoriasis
D: Psoriasis
Answer: D: Psoriasis 
Explanation: Tildrakizumab was approved by FDA in 2018 to treat adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy